BNP PARIBAS FINANCIAL MARKETS - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 55 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,259,702
+89.4%
16,651,000
+76.0%
0.02%
+75.0%
Q1 2023$8,584,042
-42.6%
9,459,000
-41.6%
0.01%
-47.8%
Q4 2022$14,947,321
-98.9%
16,192,000
+1058.2%
0.02%
+1050.0%
Q3 2022$1,381,406,0001,398,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 54,800,000$53,728,9343.15%
CSS LLC/IL 27,690,000$27,111,9721.78%
BRAIDWELL LP 52,740,000$51,764,3101.64%
Sonora Investment Management Group, LLC 12,648,000$12,375,1971.06%
CAMDEN ASSET MANAGEMENT L P /CA 24,900,000$24,314,8500.90%
DeepCurrents Investment Group LLC 20,000,000$19,514,0730.85%
Magnetar Financial LLC 28,500,000$27,924,1660.71%
TENOR CAPITAL MANAGEMENT Co., L.P. 32,000,000$31,366,1230.67%
MACKAY SHIELDS LLC 23,902,000$24,063,6470.66%
SHENKMAN CAPITAL MANAGEMENT INC 8,210,000$8,155,8490.61%
View complete list of IONIS PHARMACEUTICALS INC shareholders